Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Biotech SPDR (NY: XBI )

68.46 -0.14 (-0.20%)
Official Closing Price Updated: 8:00 PM EDT, May 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,149,940
Open 68.27
Bid (Size) 68.60 (4)
Ask (Size) 68.69 (10)
Prev. Close 68.60
Today's Range 67.35 - 70.51
52wk Range 61.78 - 141.50
Shares Outstanding 833,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield
Now that all major biopharmaceutical earnings are in, we can review the financial metrics and see if our portfolio needs re-balancing. 
Via Talk Markets
When Will The Stock Market Stop Falling?
Stocks have fallen dramatically just this past week, is a bottom near? 
Via Talk Markets

Performance

YTD
-40.70%
-40.70%
1 Month
-18.10%
-18.10%
3 Month
-25.43%
-25.43%
6 Month
-44.74%
-44.74%
1 Year
-45.94%
-45.94%

More News

Read More
Stocks Tank On May 11 With No Bottom In Sight
Via Talk Markets
7 Biotech Stocks With Key Catalysts for May
Via InvestorPlace
Should Biotech Be On The Critical List?
Via Talk Markets
The “Shake It Off” Stock Market (And Sentiment Results)
Via Talk Markets
“Threading The Needle” Stock Market (And Sentiment Results)
Via Talk Markets
7 Monster Stock Market Predictions For The Week Of April 25
Via Talk Markets
The “magic Chart” Stock Market (And Sentiment Results)
Via Talk Markets
4 Undervalued Biotech Stocks to Add to Your Buy List
Via InvestorPlace
Healthcare Stocks Lead the Way Up as the Market Fades
Via Talk Markets
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
Via InvestorPlace
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
Via InvestorPlace
Sunshine Biopharma Stock Triples on Positive mRNA Cancer Treatment Results
Via InvestorPlace
Good Entry Point for Biotech Stocks
Via Talk Markets
CNBC's Final Call: Newmont, Biotech ETF And This Energy Stock
Via Benzinga
Acadia: Helping With Alzheimers And Parkinsons
Via Talk Markets
Biotech Funds and ETFs Continue to Lag
Via Talk Markets
How do Biotechnology Funds and ETFs Perform Over Five Years?
Via Talk Markets
AskSlim Market Week - Friday, March 18
Via Talk Markets
3 Market ETF Stocks to Buy This Week on Fed Jitters
Via InvestorPlace
Tough Slogging Ahead for Investors, Diversification is Important
Via Talk Markets
3 Moonshot Stocks Insiders Are Buying. What Do They Know?
Via InvestorPlace
3 Desirable Drug Stocks With Very Promising Pipelines
Via InvestorPlace
Large Cap Biopharma- Well Positioned For Choppy Markets
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.